MDCE Medical Care Technologies Inc.
Services-Business Services, NEC · OTC · SEC CIK 1404593 · Fiscal year ends 12/31
Financial factors as of 2012-09-30 (2012Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-64.4%
TTM EPS YoY100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-395.8%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets119.8%
Debt / equity—
Current ratio0.16x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.10x
Accruals ratio-354.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2012Q32012-09-30 | 2012Q22012-06-30 | 2012Q12012-03-31 | 2011Q4*2011-12-31 | 2011Q32011-09-30 | 2011Q22011-06-30 | 2011Q12011-03-31 | 2010Q4*2010-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| SG&A expense | $372,569 | $320,612 | $93,691 | $148,808 | $223,073 | $437,136 | $67,017 | $130,021 |
| Interest expense | $136,938 | $137,644 | $92,481 | $164,015 | $135,748 | $175,035 | $12,369 | $341 |
| Pretax income | -$711,129 | -$1.34M | -$378,217 | -$468,456 | -$504,397 | -$834,029 | -$127,666 | -$292,165 |
| Net income | -$709,811 | -$1.34M | -$371,771 | -$463,993 | -$501,540 | -$832,141 | -$126,213 | -$292,165 |
| EPS (basic) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 2.51B | — | — | — | 229.92M | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $742 | $379 | $784 | $3,380 | $26,698 | $24,195 | $6,791 | $391 |
| Current assets | $221,810 | $203,982 | $43,853 | $45,062 | $293,489 | $342,091 | — | $6,891 |
| PP&E, net | $31,002 | $31,002 | $20,151 | $6,200 | $2,500 | $5,000 | — | $10,000 |
| Intangibles | $897,148 | $897,148 | $457,695 | $457,695 | — | — | — | $0 |
| Total assets | $1.15M | $1.13M | $552,955 | $513,921 | $302,966 | $353,985 | — | $16,891 |
| Current liabilities | $1.38M | $1.46M | $571,761 | $521,455 | — | — | — | $246,253 |
| Total liabilities | $1.38M | $1.46M | $703,766 | $652,409 | $447,285 | $486,067 | — | $246,253 |
| Shareholders' equity | -$228,469 | -$331,068 | -$295,525 | -$138,488 | -$235,636 | -$226,231 | — | -$229,362 |
| Shares outstanding | 3.24B | 1.84B | 566.39M | 328.90M | 244.47M | 213.02M | — | 161.01M |
| Cash flow statement | ||||||||
| Operating cash flow | -$87,696 | -$51,820 | -$58,139 | -$102,113 | -$94,056 | -$103,551 | -$72,200 | -$31,922 |
| Investing cash flow | $285,645 | — | — | -$206,200 | — | — | — | $0 |
| Financing cash flow | -$197,586 | $490,868 | $55,543 | $284,995 | $354,254 | $120,955 | $78,600 | $31,128 |
| Depreciation & amortization | — | — | — | -$8,402 | $8,942 | $6,960 | $2,500 | $149,072 |
| Stock-based compensation | $41,000 | $444,478 | $40,026 | $57,065 | $207,146 | $473,816 | $50,159 | $79,622 |
Free plan shows the latest 8 periods; Pro shows all 10 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.